Biotin Supplementation Safety and Considerations

Introduction to Biotin Safety

• The American College of Nutrition and other major nutrition societies have not established an upper tolerable limit (UL) for biotin, indicating its safety profile, with no adverse effects reported at doses up to 5 mg/day for prolonged periods 1, 2
• Biotin toxicity is unlikely, and high doses up to 300 mg/day have been used extensively in parenteral nutrition for years without toxicity issues 1, 2

Safety Profile in General Population

• No adverse effects have been documented with either oral or intravenous administration of pharmacological doses up to 5 mg/day for extended periods 1, 2
• The ESPEN 2022 guidelines provide Grade B recommendations for doses of 30-60 mcg/day in standard nutrition, with strong consensus (95-100%) on safety 1, 2

Special Considerations for Kidney Disease

• Patients with chronic kidney disease have compromised biotin absorption and altered status, but supplementation remains safe when properly monitored 3, 4
• Intestinal absorption of biotin may be compromised in CKD patients 3, 4
• Patients on renal replacement therapy may require additional biotin amounts beyond standard recommendations 1, 2
• Intake equal to the Dietary Reference Intake (DRI) should be provided through diet and/or supplementation 3, 4

Pregnancy and Lactation Considerations

• The National Academy of Sciences recommends ensuring at least 35 mcg/day orally for breastfeeding mothers, with potential increases up to 300 mcg/day in pregnancy based on metabolic markers 1, 2, 5